[go: up one dir, main page]

WO2011057269A3 - Compositions for enhancing hair growth - Google Patents

Compositions for enhancing hair growth Download PDF

Info

Publication number
WO2011057269A3
WO2011057269A3 PCT/US2010/056036 US2010056036W WO2011057269A3 WO 2011057269 A3 WO2011057269 A3 WO 2011057269A3 US 2010056036 W US2010056036 W US 2010056036W WO 2011057269 A3 WO2011057269 A3 WO 2011057269A3
Authority
WO
WIPO (PCT)
Prior art keywords
compositions
hair growth
enhancing hair
human
growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2010/056036
Other languages
French (fr)
Other versions
WO2011057269A2 (en
Inventor
Anuradha Gore
Kevin S. Warner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Inc
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Priority to US13/509,040 priority Critical patent/US20130011354A1/en
Priority to CA2780925A priority patent/CA2780925A1/en
Priority to EP10779398A priority patent/EP2498784A2/en
Priority to AU2010314863A priority patent/AU2010314863A1/en
Publication of WO2011057269A2 publication Critical patent/WO2011057269A2/en
Anticipated expiration legal-status Critical
Publication of WO2011057269A3 publication Critical patent/WO2011057269A3/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A61K8/062—Oil-in-water emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Methods and compositions for stimulating the growth of hair are disclosed wherein emulsions include a cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl compound represented by the formula I wherein the dashed bonds represent a single or double bond which can be in the cis or trans configuration, A, B, Z, X, R1 and R2 are as defined in the specification. Such compositions are used in treating the skin or scalp of a human or non-human animal.
PCT/US2010/056036 2009-11-09 2010-11-09 Compositions for enhancing hair growth Ceased WO2011057269A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US13/509,040 US20130011354A1 (en) 2009-11-09 2010-11-09 Compositions For Enhancing Hair Growth
CA2780925A CA2780925A1 (en) 2009-11-09 2010-11-09 Compositions for enhancing hair growth
EP10779398A EP2498784A2 (en) 2009-11-09 2010-11-09 Compositions for enhancing hair growth
AU2010314863A AU2010314863A1 (en) 2009-11-09 2010-11-09 Compositions for enhancing hair growth

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US25936809P 2009-11-09 2009-11-09
US61/259,368 2009-11-09
US26016309P 2009-11-11 2009-11-11
US61/260,163 2009-11-11

Publications (2)

Publication Number Publication Date
WO2011057269A2 WO2011057269A2 (en) 2011-05-12
WO2011057269A3 true WO2011057269A3 (en) 2012-07-26

Family

ID=43827516

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2010/056036 Ceased WO2011057269A2 (en) 2009-11-09 2010-11-09 Compositions for enhancing hair growth

Country Status (5)

Country Link
US (2) US20110112198A1 (en)
EP (1) EP2498784A2 (en)
AU (1) AU2010314863A1 (en)
CA (1) CA2780925A1 (en)
WO (1) WO2011057269A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8758733B2 (en) 2002-02-04 2014-06-24 Allergan, Inc. Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
US9216183B2 (en) 2002-02-04 2015-12-22 Allergan, Inc. Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
US7351404B2 (en) 2002-02-04 2008-04-01 Allergan, Inc. Method of enhancing hair growth
US20100204335A1 (en) * 2008-12-01 2010-08-12 Allergan, Inc. Kit and composition for eyelash growth
CN102724951A (en) * 2009-11-09 2012-10-10 阿勒根公司 Compositions and methods for stimulating hair growth
US9149484B2 (en) 2009-11-09 2015-10-06 Allergan, Inc. Compositions and methods for stimulating hair growth
HK1207961A1 (en) * 2011-11-25 2016-02-19 阿德里安娜‧贾内尔‧杰克逊 Oil composition and method for increasing hair growth and/or preventing hair loss
US10211724B1 (en) * 2017-12-20 2019-02-19 Micron Technology, Inc. Electronic device with an output voltage booster mechanism

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030147823A1 (en) * 2002-02-04 2003-08-07 Allergan, Inc. Method of enhancing hair growth
WO2006050836A2 (en) * 2004-11-09 2006-05-18 Novagali Pharma Sa Ophthalmic emulsions containing prostaglandins
EP1681059A1 (en) * 2003-11-07 2006-07-19 Senju Pharmaceutical Co., Ltd. Pharmaceutical composition containing prostaglandin
US20080275118A1 (en) * 2008-06-12 2008-11-06 Shaw Mari M Health and cosmetic composition and regime for stimulating hair growth and thickening on the head, including the scalp, eyelashes, and eyebrows, and which discourages hair loss
US7514474B1 (en) * 2007-10-31 2009-04-07 Meta Cosmetics, Llc Prostaglandin analog compositions and methods to treat epithelial-related conditions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4139619A (en) 1976-05-24 1979-02-13 The Upjohn Company 6-Amino-4-(substituted amino)-1,2-dihydro-1-hydroxy-2-iminopyrimidine, topical compositions and process for hair growth
US4968812A (en) 1989-06-23 1990-11-06 Shell Oil Company Spirolactonelactams
US5352708A (en) * 1992-09-21 1994-10-04 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5789244A (en) * 1996-01-08 1998-08-04 Canji, Inc. Compositions and methods for the treatment of cancer using recombinant viral vector delivery systems
JP4397973B2 (en) 1997-02-04 2010-01-13 ジョンストン， マーレイ エイ． Topical composition for stimulating hair growth of wrinkles
US6646001B2 (en) * 1997-12-19 2003-11-11 Alcon Manufacturing, Ltd. Use of non-steroidal anti-inflammatory agents in combination with prostaglandin FP receptor agonists to treat glaucoma and ocular hypertension
DE602004017477D1 (en) * 2004-11-09 2008-12-11 Novagali Pharma Sa Oil-in-water emulsion with low concentration of cationic agent and positive zeta potential
GB0501192D0 (en) * 2005-01-20 2005-03-02 Resolution Chemicals Ltd Stable prostaglandin-containing compositions
US20070254920A1 (en) * 2006-04-26 2007-11-01 Aerie Pharmaceuticals, Inc. Prodrug derivatives of acids using alcohols with homotopic hydroxy groups and methods for their preparation and use

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030147823A1 (en) * 2002-02-04 2003-08-07 Allergan, Inc. Method of enhancing hair growth
EP1681059A1 (en) * 2003-11-07 2006-07-19 Senju Pharmaceutical Co., Ltd. Pharmaceutical composition containing prostaglandin
WO2006050836A2 (en) * 2004-11-09 2006-05-18 Novagali Pharma Sa Ophthalmic emulsions containing prostaglandins
US7514474B1 (en) * 2007-10-31 2009-04-07 Meta Cosmetics, Llc Prostaglandin analog compositions and methods to treat epithelial-related conditions
US20080275118A1 (en) * 2008-06-12 2008-11-06 Shaw Mari M Health and cosmetic composition and regime for stimulating hair growth and thickening on the head, including the scalp, eyelashes, and eyebrows, and which discourages hair loss

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
TOSTI A ET AL: "Hypertrichosis of the eyelashes caused by bimatoprost", JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, C.V. MOSBY, ST. LOUIS, MO, US, vol. 51, no. 5, 1 November 2004 (2004-11-01), pages S149 - S150, XP004666637, ISSN: 0190-9622, DOI: 10.1016/J.JAAD.2004.05.002 *

Also Published As

Publication number Publication date
CA2780925A1 (en) 2011-05-12
US20130011354A1 (en) 2013-01-10
US20110112198A1 (en) 2011-05-12
EP2498784A2 (en) 2012-09-19
AU2010314863A1 (en) 2012-06-14
WO2011057269A2 (en) 2011-05-12

Similar Documents

Publication Publication Date Title
WO2011057129A3 (en) Compositions and methods for stimulating hair growth
WO2011057269A3 (en) Compositions for enhancing hair growth
HK1220384A1 (en) Topical compositions comprising bimatoprost and methods for stimulating hair growth therewith
WO2012072245A3 (en) Exopolysaccharide for the treatment and/or care of the skin, mucous membranes, hair and/or nails
EP2250996A3 (en) Method of enhancing hair growth
IN2012DN02679A (en)
WO2009098188A3 (en) Composition and method for seed treatment use
WO2012002724A3 (en) Method for preparing a hair and scalp condition-enhancing composition with increased efficacy of blending aroma oil
WO2009118107A3 (en) Skin care composition
EP2371347A3 (en) Oral care compositions
WO2010009127A3 (en) Tooth whitening compositions and methods
WO2011073279A3 (en) Cosmetic treatment method involving a compound capable of condensing in situ
MX363465B (en) Treatment of submental fat.
WO2013025765A3 (en) Methods of reducing odor
WO2013096611A3 (en) Compositions and methods for improving the appearance of aging hair
WO2011100671A3 (en) Methods and compositions to improve mechanical resistance of teeth
WO2012087779A3 (en) Hair care compositions and methods to improve hair appearance
WO2010012386A3 (en) Method for treating hypersensitive teeth
WO2012000946A3 (en) Synergistic active ingredient combinations containing penflufen
WO2008081142A3 (en) Oral use of at least one monounsaturated fatty acid for hair improvement
WO2010110863A3 (en) Compositions and methods for promoting hair growth
WO2011145872A3 (en) Composition for preventing hair-loss or stimulating hair growth
WO2012012798A3 (en) Materials and methods for reduction of protein tau and treatment of neurodegenerative diseases
WO2011001111A3 (en) Use of jasmonic acid to treat oily skin
WO2011151426A3 (en) Carotenoid sunscreen

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10779398

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2780925

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2010314863

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2010779398

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2010314863

Country of ref document: AU

Date of ref document: 20101109

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 13509040

Country of ref document: US